Skip to main content
. 2020 Sep 22;71(2):331–343. doi: 10.1007/s12020-020-02496-x

Fig. 1.

Fig. 1

Distribution of all adverse events (AEs) reported by the total population of enrolled patients (N. 63 subjects with obesity). Data are expressed as percentage (%) of the total number of AEs (N. 52 AEs)